SEC16B identified as a regulator of VLDL secretion and lipid accumulation in the liver
Open Access
- 2 June 2026
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (14)
Abstract
The liver plays a major role in regulating the metabolic fate of lipids and facilitates lipid secretion to peripheral organs in the form of VLDLs or lipid storage in lipid droplets (LDs). Hepatic regulation of excess lipids profoundly influences the development of atherosclerosis; thus, uncovering the regulatory mechanisms underlying lipid storage and secretion pathways may reveal additional therapeutic targets. In this issue of the JCI , Lu et al. identified a pathway involving SEC16B, showing that this protein functions as a lipid-responsive regulator and mediates VLDL secretion and LD formation to maintain lipid homeostasis. They also demonstrated that a reduction in SEC16B reduced serum lipid levels and atherosclerotic plaque area in Ldlr –/– mice. These results indicate that SEC16B connects VLDL and LD metabolism, positioning SEC16B as a potential therapeutic avenue for atherosclerosis.Keywords
This publication has 24 references indexed in Scilit:
- Tissue-selective COPII modulator SEC16B aggravates cardiovascular disease by promoting lipid exportThe EMBO Journal, 2026
- Concept of lipid droplet biogenesisEuropean Journal of Cell Biology, 2023
- Lipid droplet biogenesis and functions in health and diseaseNature Reviews Endocrinology, 2023
- The power of genetic diversity in genome-wide association studies of lipidsNature, 2021
- Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLDMolecular Metabolism, 2021
- The changing landscape of atherosclerosisNature, 2021
- Hepatic lipid droplet homeostasis and fatty liver diseaseSeminars in Cell & Developmental Biology, 2020
- The hepatic lipidome: From basic science to clinical translationAdvanced Drug Delivery Reviews, 2020
- Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistanceTrends in Endocrinology & Metabolism, 2011
- The many intersecting pathways underlying apolipoprotein B secretion and degradationTrends in Endocrinology & Metabolism, 2008